These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6134424)

  • 1. Aspects of inhibition of myometrial hyperactivity in primary dysmenorrhea.
    Forman A; Ulmsten U; Andersson KE
    Acta Obstet Gynecol Scand Suppl; 1983; 113():71-6. PubMed ID: 6134424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
    Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
    J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium channel blockers on the female genital tract.
    Forman A; Andersson KE; Maigaard S
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():183-92. PubMed ID: 3521196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of uterine activity.
    Andersson KE
    Acta Obstet Gynecol Scand Suppl; 1982; 108():17-23. PubMed ID: 6126985
    [No Abstract]   [Full Text] [Related]  

  • 5. Mares with delayed uterine clearance have an intrinsic defect in myometrial function.
    Rigby SL; Barhoumi R; Burghardt RC; Colleran P; Thompson JA; Varner DD; Blanchard TL; Brinsko SP; Taylor T; Wilkerson MK; Delp MD
    Biol Reprod; 2001 Sep; 65(3):740-7. PubMed ID: 11514336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and dysmenorrhea.
    Andersson KE
    Ann N Y Acad Sci; 1988; 522():747-56. PubMed ID: 3288067
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium entry blockade as a therapeutic principle in the female urogenital tract.
    Forman A
    Acta Obstet Gynecol Scand Suppl; 1984; 121():1-26. PubMed ID: 6588719
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the spontaneous motor activity of the isolated human pregnant myometrium.
    Poli E; Merialdi A; Coruzzi G
    Pharmacol Res; 1990; 22(2):115-24. PubMed ID: 1691846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.
    Lundström V
    Acta Obstet Gynecol Scand; 1977; 56(3):167-72. PubMed ID: 878858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rationale for the treatment of dysmenorrhea.
    Csapo AI
    J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?
    Lumsden MA; Kelly RW; Baird DT
    Prostaglandins; 1983 May; 25(5):683-92. PubMed ID: 6577521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in dysmenorrhea.
    Ylikorkala O; Dawood MY
    Am J Obstet Gynecol; 1978 Apr; 130(7):833-47. PubMed ID: 25021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of mare uterus motility with special reference to calcium antagonists and beta-2-adrenergic stimulants.
    Coruzzi G; Poli E; Montanari C; Bertaccini G
    Gen Pharmacol; 1989; 20(4):513-8. PubMed ID: 2568969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins and the non-pregnant uterus. The pathophysiology of primary dysmenorrhea.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1983; 113():63-7. PubMed ID: 6344545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxant effects of nifedipine on isolated, human myometrium.
    Forman A; Andersson KE; Persson CG; Ulmsten U
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):81-6. PubMed ID: 495117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea.
    Andersson KE; Ulmsten U
    Br J Obstet Gynaecol; 1978 Feb; 85(2):142-8. PubMed ID: 626724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium blockade as a rapid pharmacological test to evaluate primary dysmenorrhea.
    Ulmsten U
    Gynecol Obstet Invest; 1985; 20(2):78-83. PubMed ID: 4054731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-uterine pressure in dysmenorrhea.
    Lumsden MA; Baird DT
    Acta Obstet Gynecol Scand; 1985; 64(2):183-6. PubMed ID: 3984694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of dysmenorrhea.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1979; 87():27-32. PubMed ID: 380250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.